All Texas Biomedical Research Institute articles
-
News
Zika vaccine safe, effective when administered during pregnancy
A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according to new research.
-
News
Scientists discover Ebola virus uses tunnelling nanotubes to infect cells
A new study indicates that Ebola virus creates and uses intercellular tunnels to move from cell to cell within the human body and evade treatments.
-
News
Cancer therapy shows promise against tuberculosis
A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB).
-
News
Texas Biomed partners with Scancell to test novel COVID vaccine
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed).
-
News
Second gene implicated in malaria chloroquine resistance evolution
How malaria parasites evolved to evade a major antimalarial drug has long been thought to involve only one key gene. Now, scientists have shown a second key gene is also involved in malaria’s resistance to the drug chloroquine.
-
News
HIV vaccine candidate aims to block virus before it takes root
The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.